Page 9 - CUAJ April 2019: Surveillance urodynamics for neurogenic lower urinary tract dysfunction: A systematic review

Surveillance urodynamics for neurogenic lower urinary tract dysfunction

20. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: 32. Ciancio SJ, Mutchnik SE, Rivera VM, et al. Urodynamic pattern changes in multiple sclerosis. Urology
The PRISMA statement. Ann Intern Med 2009;151:264-9. https://doi.org/10.7326/0003-4819- 2001;57:239-45. https://doi.org/10.1016/S0090-4295(00)01070-0
151-4-200908180-00135 33. Schoenberg HW, Gutrich JM. Management of vesical dysfunction in multiple sclerosis. Urology
21. Oxford Centre for Evidence-based Medicine – Levels of Evidence [Internet]. 2009. Available at: 1980;16:444-7. https://doi.org/10.1016/0090-4295(80)90162-4
http://www.cebm.net/oxford-centre-evidence-based-medicine-levels-evidence-march-2009/. Accessed 34. Wheeler JS Jr, Siroky MB, Pavlakis AJ, et al. The changing neurourologic pattern of multiple sclerosis.
Feb. 12, 2019. J Urol 1983;130:1123-6. https://doi.org/10.1016/S0022-5347(17)51716-4
22. Linsenmeyer TA, Linsenmeyer MA. Impact of annual urodynamic evaluations on guiding bladder manage- 35. Goldstein I, Siroky MB, Sax DS, et al. Neurourologic abnormalities in multiple sclerosis. J Urol
ment in individuals with spinal cord injuries. J Spinal Cord Med 2013;36:420-6. https://doi.org/10.1 1982;128:541-5. https://doi.org/10.1016/S0022-5347(17)53037-2
179/2045772313Y.0000000106 36. Blaivas JG, Bhimani G, Labib KB. Vesicourethral dysfunction in multiple sclerosis. J Urol 1979;122:342-7.
23. Nosseir M, Hinkel A, Pannek J. Clinical usefulness of urodynamic assessment for maintenance https://doi.org/10.1016/S0022-5347(17)56397-1
of bladder function in patients with spinal cord injury. Neurourol Urodyn 2007;26:228-33. 37. Bemelmans BL, Hommes OR, Van Kerrebroeck PE, et al. Evidence for early lower urinary tract dysfunction
https://doi.org/10.1002/nau.20319 in clinically silent multiple sclerosis. J Urol 1991;145:1219-24. https://doi.org/10.1016/S0022-
24. Edokpolo LU, Foster HE Jr. Renal tract ultrasonography for routine surveillance in spinal cord injury patients. 5347(17)38581-6
Top Spinal Cord Inj Rehabil 2013;19:54-60. https://doi.org/10.1310/sci1901-54 38. Litwiller SE, Frohman EM, Zimmern PE. Multiple sclerosis and the urologist. J Urol 1999;161:743-57.
25. Spindel MR, Bauer SB, Dyro FM, et al. The changing neurourologic lesion in myelodysplasia. JAMA https://doi.org/10.1016/S0022-5347(01)61760-9
1987;258:1630-3. https://doi.org/10.1001/jama.1987.03400120080029 39. Fletcher SG, Dillon BE, Gilchrist AS, et al. Renal deterioration in multiple sclerosis patients with neurovesical
26. Almodhen F, Capolicchio JP, Jednak R, et al. Postpubertal urodynamic and upper urinary tract dysfunction. Mult Scler 2013;19:1169-74. https://doi.org/10.1177/1352458512474089
changes in children with conservatively treated myelomeningocele. J Urol 2007;178:1479-82. 40. Schops TF, Schneider MP, Steffen F, et al. Neurogenic lower urinary tract dysfunction (NLUTD) in
https://doi.org/10.1016/j.juro.2007.05.171 patients with spinal cord injury: Long-term urodynamic findings. BJU Int 2015;115Suppl6:33-8.
27. Tarcan T, Bauer S, Olmedo E, et al. Long-term followup of newborns with myelodysplasia and normal urody- https://doi.org/10.1111/bju.13085
namic findings: Is followup necessary? J Urol 2001;165:564-7. https://doi.org/10.1097/00005392- 41. Chao R, Mayo ME. Long-term urodynamic follow up in pediatric spinal cord injury. Paraplegia 1994;32:806-9.
200102000-00070
28. Bruschini H, Almeida FG, Srougi M. Upper and lower urinary tract evaluation of 104 patients with Correspondence: Dr. Alex Kavanagh, Department of Urologic Sciences, University of British Columbia,
myelomeningocele without adequate urological management. World J Urol 2006;24:224-8. Vancouver, BC, Canada; clinic@ubcurology.com
https://doi.org/10.1007/s00345-006-0087-x
29. Edelstein RA, Bauer SB, Kelly MD, et al. The long-term urological response of neonates with myelodysplasia
treated proactively with intermittent catheterization and anticholinergic therapy. J Urol 1995;154:1500-4. To answer the multiple-choice questions associated with this article, go to:
https://doi.org/10.1016/S0022-5347(01)66914-3 www.cuasection3credits.org/cuajapril2019. This program is an Accredited Self-Assessment
30. Kaufman AM, Ritchey ML, Roberts AC, et al. Decreased bladder compliance in patients with myelome- Program (Section 3) as defined by the Maintenance of Certification Program of The Royal College
ningocele treated with radiological observation. J Urol 1996;156:2031-3. https://doi.org/10.1016/ of Physicians & Surgeons of Canada, and approved by the Canadian Urological Association.
S0022-5347(01)65427-2 Remember to visit MAINPORT (www.mainport.org/mainport/) to record your learning and
31. Hopps CV, Kropp KA. Preservation of renal function in children with myelomeningocele managed with outcomes. You may claim a maximum of 1 hour of credit.
basic newborn evaluation and close followup. J Urol 2003;169:305-8. https://doi.org/10.1016/
S0022-5347(05)64112-2

CUAJ is now offering its readers the opportunity to claim Section 3
Self-Assessment credits of the Maintenance of Certification (MOC) Program!

Every second issue (February, April, June, August,
October, and December), a specific paper will be
accredited by the Canadian Urological Association (CUA).
CLAIM YOUR CREDITS IN 3 EASY STEPS:

1 Go to www.cuaj.ca, read the accredited paper, and answer
the three multiple choice questions associated with it.
Enter your name and email to receive
2
a certificate of participation from CUA.
3
Log the self-learning activity and record
learning/outcomes in your Royal College
MAINPORT account.

cuaj.ca

CUAJ • April 2019 • Volume 13, Issue 4 141